FERRARI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.347
NA - Nord America 28.772
AS - Asia 11.249
SA - Sud America 1.878
AF - Africa 298
Continente sconosciuto - Info sul continente non disponibili 297
OC - Oceania 52
Totale 71.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.127
IT - Italia 18.792
GB - Regno Unito 3.962
CN - Cina 3.190
SG - Singapore 2.987
NL - Olanda 1.410
BR - Brasile 1.397
VN - Vietnam 1.322
HK - Hong Kong 1.253
SE - Svezia 880
DE - Germania 871
FR - Francia 698
UA - Ucraina 657
BD - Bangladesh 549
FI - Finlandia 541
RU - Federazione Russa 437
KR - Corea 406
TR - Turchia 394
CA - Canada 307
IN - India 260
BG - Bulgaria 231
CH - Svizzera 222
MX - Messico 162
ID - Indonesia 149
AR - Argentina 134
ES - Italia 97
JP - Giappone 92
IE - Irlanda 85
EC - Ecuador 80
IQ - Iraq 80
CO - Colombia 70
PL - Polonia 69
ZA - Sudafrica 68
PK - Pakistan 67
CL - Cile 61
IR - Iran 55
AU - Australia 48
BE - Belgio 46
EG - Egitto 46
MY - Malesia 46
CZ - Repubblica Ceca 45
PH - Filippine 45
AE - Emirati Arabi Uniti 44
MA - Marocco 42
PE - Perù 42
CR - Costa Rica 40
SA - Arabia Saudita 40
TW - Taiwan 37
VE - Venezuela 37
GR - Grecia 35
UZ - Uzbekistan 33
TN - Tunisia 31
JM - Giamaica 29
PY - Paraguay 29
AT - Austria 25
DK - Danimarca 25
DZ - Algeria 25
KE - Kenya 25
EU - Europa 24
RO - Romania 24
SK - Slovacchia (Repubblica Slovacca) 24
TH - Thailandia 24
HU - Ungheria 23
PT - Portogallo 22
RS - Serbia 21
NP - Nepal 20
LT - Lituania 19
BO - Bolivia 18
DO - Repubblica Dominicana 18
AZ - Azerbaigian 16
JO - Giordania 16
HN - Honduras 14
IL - Israele 14
TT - Trinidad e Tobago 13
NO - Norvegia 12
PR - Porto Rico 12
AL - Albania 11
KZ - Kazakistan 11
NG - Nigeria 11
SN - Senegal 11
LB - Libano 10
NI - Nicaragua 10
OM - Oman 10
BY - Bielorussia 9
ET - Etiopia 9
KG - Kirghizistan 9
PA - Panama 9
SI - Slovenia 9
UY - Uruguay 9
GE - Georgia 8
HR - Croazia 8
MN - Mongolia 8
SC - Seychelles 8
SV - El Salvador 8
BH - Bahrain 7
GT - Guatemala 7
LU - Lussemburgo 7
LV - Lettonia 7
PS - Palestinian Territory 7
QA - Qatar 7
Totale 71.521
Salva come PNG Salva come JPEG
Città #
Ashburn 3.004
Southend 2.835
Milan 2.094
Santa Clara 2.066
Fairfield 1.876
Singapore 1.853
Woodbridge 1.382
Jacksonville 1.291
Hong Kong 1.227
Chandler 1.146
San Jose 1.001
Houston 976
Hefei 870
Rome 824
Wilmington 740
Ann Arbor 728
Chicago 726
Council Bluffs 725
Seattle 710
Dearborn 709
Beijing 678
Cambridge 645
Jersey City 591
Los Angeles 550
Turin 523
London 504
Nyköping 476
Ho Chi Minh City 439
Seoul 338
Helsinki 329
The Dalles 309
Hanoi 306
Salt Lake City 287
Florence 266
New York 256
Princeton 255
Modena 251
Genoa 246
Bologna 231
Brescia 220
Sofia 220
Eugene 206
Izmir 199
Dallas 186
Columbus 181
Lauterbourg 181
San Diego 177
Buffalo 153
Naples 152
Moscow 150
Redwood City 144
Elk Grove Village 140
Tampa 130
São Paulo 124
Verona 117
Orem 112
Bergamo 104
Shanghai 96
Frankfurt am Main 89
Monza 86
Sterling 85
Jakarta 82
Perugia 81
Trenton 81
Falls Church 77
Palermo 77
Dublin 76
Des Moines 74
Phoenix 73
Da Nang 72
Padova 71
Parma 71
Miami 69
Lancaster 67
Toronto 67
Bari 66
Catania 66
Pescara 65
Boardman 64
Tokyo 61
Chennai 60
Brooklyn 59
Norwalk 59
Atlanta 55
Haiphong 55
Guangzhou 53
Venice 53
Munich 51
Trieste 51
Mexico City 49
Montreal 46
Nanjing 46
Fremont 45
Dulles 44
Denver 43
Detroit 43
Paris 42
Reggio Emilia 42
Bremen 41
Rio de Janeiro 40
Totale 39.852
Salva come PNG Salva come JPEG
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 11.194
Krokodil: The drug that kills 6.188
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.365
Atogepant: an emerging treatment for migraine 987
Allopregnanolone serum levels in female migraineurs 906
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 751
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 680
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 522
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 511
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 502
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 490
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 471
Methadone - metabolism, pharmacokinetics and interactions 468
Effective prophylactic treatments of migraine lower plasma glutamate levels 467
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 452
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 446
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 446
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 440
Past, present, and future prospects of medication-overuse headache classification 435
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 433
Le neuropatie da farmaci 432
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 429
Clinical pharmacology of topiramate in migraine prevention 422
How children and parents evaluate the headache centre's intervention 417
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 415
Monitoring of adherence to headache treatments by means of hair analysis 407
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 406
Effect of sumatriptan in different models of pain in rats 402
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 397
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 397
Similarities and differences between chronic migraine and episodic migraine 393
Paracetamol: new vistas of an old drug 392
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 389
Basal cutaneous pain threshold in headache patients 381
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 379
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 370
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 369
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 369
Adverse reactions related to drugs for headache treatment: clinical impact 364
Paracetamol revisited 363
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 358
Headache: one of the most common and troublesome adverse reactions to drugs. 356
Abuse of tramadol in a binge pattern in a young woman 355
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 348
Farmacologia e Tossicologia 339
Analgesic drug taking: Beliefs and behavior among headache patients 335
Triptans: what is the clinical importance of kinetic differences? 320
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 318
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 309
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 307
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 305
Italian guidelines for primary headaches: 2012 revised version. 297
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 297
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 296
Focus on headache as an adverse reaction to drugs 294
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 291
Headache as an Adverse Reaction to Medication 283
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 280
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 278
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 277
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 276
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 275
Polypharmacy Among Headache Patients: A Cross-Sectional Study 274
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 274
Pharmacoepidemiology of triptans in a headache centre 273
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 269
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 269
Hair testing as a marker of adherence to headache treatments 268
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 264
Glutamate receptor antagonists with the potential for migraine treatment 261
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 260
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 259
Proteomic serum profile in menstrual-related and post menopause migraine 258
Analgesic abuse in chronic headache sufferers 257
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 256
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 255
Trattamento farmacologico del dolore postoperatorio 254
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 253
Assessment of the efficacy and tolerability of triptans in clinical practice 251
Accanimento terapeutico o riduzione del danno 248
Evalutation of proteomic profile in menstrually-related migraine 248
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 248
Proteomic serum profile of female migraineurs 247
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 245
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 242
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 240
Adolescenza, sostanze stupefacenti, riti di passaggio 240
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 238
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 238
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 237
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 236
Plasma glutathione level in chronic headache drug abuser patients 230
Influence of chronic therapy with flunarizine on glucose, insulin and C-peptide metabolism 230
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 230
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 229
Evaluation of proteomic profile in menstrual-related migraine 227
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 224
Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis 223
Zopiclone and prazepam abuse in a chronic migraine patient 219
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 217
Totale 53.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.805 0 0 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/202512.633 679 491 494 937 1.951 1.498 1.029 909 1.428 869 1.196 1.152
2025/202621.365 1.890 1.183 1.817 2.773 3.635 1.370 2.194 1.255 1.611 1.573 1.182 882
2026/20274.308 1.077 1.548 1.683 0 0 0 0 0 0 0 0 0
Totale 71.893